| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/06/2008 | US7368578 superior in an adipose tissue weight decreasing action and a retinoid-related receptor function regulating action; to treat obesity, diabetes mellitus, hyperlipidemia, impaired glucose tolerance, hypertension; fewer side effects; 4-{[2-(2-furyl)-1,3-oxazol-4-yl]methoxy}-3-methoxybenzaldehyde |
| 05/06/2008 | US7368574 crystalline hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, used as hypoglycemic, antilipemic or antidiabetic agents |
| 05/06/2008 | US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368469 Prophylaxis of stroke, cardiovascular death or myocardial infarction by administering an angiotenzin converting enzyme inhibitor: ramipril, ramiprilat or their salts, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic or aspirin |
| 05/06/2008 | US7368427 GLP-1 analogues |
| 05/06/2008 | US7368286 Using trangenic cells overexpressing human estrogen receptor gene as model for identifying modulators for treating diabetes, obesity and insulin resistance |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
| 05/02/2008 | WO2008052087A1 Chromane derivatives and uses thereof |
| 05/02/2008 | WO2008052044A2 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 05/02/2008 | WO2008051942A2 Farnesoid x receptor agonists |
| 05/02/2008 | WO2008051902A2 Method of restoring the incretin effect |
| 05/02/2008 | WO2008051797A2 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 05/02/2008 | WO2008051794A2 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 05/02/2008 | WO2008051793A2 Method of preventing or treating metabolic syndrome |
| 05/02/2008 | WO2008050987A1 Combination formulation with controlled release comprising metformin and glimepiride |
| 05/02/2008 | WO2008050821A1 Indole compound |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050580A1 Mineral composition for prevention or treatment of diabetic disease |
| 05/02/2008 | WO2008050207A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 05/02/2008 | WO2008050117A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 05/02/2008 | WO2008049997A2 Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/02/2008 | WO2008049996A2 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/02/2008 | WO2008049923A1 CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 05/02/2008 | WO2008049806A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/02/2008 | WO2008049330A1 Use of lipocalin-2 as a diagnostic marker and therapeutic target |
| 05/02/2008 | WO2008049232A1 Novel vitamin d2 yeast preparation, a method for producing the same, and the use thereof |
| 05/02/2008 | WO2008049198A1 Composition for weight loss comprising mulberry leaf, pinolenic acid and salacia oblonga extract |
| 05/02/2008 | WO2008049196A1 Composition for improving blood cholesterol levels |
| 05/02/2008 | WO2008049194A1 Fat beta-oxidation enhancing and carbohydrate absorption inhibition supplement |
| 05/02/2008 | WO2008034989A3 Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body |
| 05/02/2008 | WO2008033932A3 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 05/02/2008 | WO2007064762A3 Conjugates of amino acids and vitamin b3 for percutaneous delivery of vitamin b3 |
| 05/02/2008 | CA2667550A1 Crystalline form of 4-(.beta.-d-glucopyranos-1-yl)-1-methyl-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 05/02/2008 | CA2667435A1 Chemical compounds |
| 05/02/2008 | CA2667316A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 05/02/2008 | CA2667231A1 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 05/02/2008 | CA2666973A1 Indole compound having a glucokinase activating action |
| 05/02/2008 | CA2666936A1 Method of preventing or treating metabolic syndrome |
| 05/02/2008 | CA2666670A1 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 05/02/2008 | CA2666538A1 Use of citrulline for treating undernutrition conditions |
| 05/02/2008 | CA2666197A1 Novel vitamin d2 yeast preparation, a method for producing the same, and the use thereof |
| 05/02/2008 | CA2664141A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 05/01/2008 | US20080103215 Screening Method |
| 05/01/2008 | US20080103208 Poly(ADP-ribose) polymerase inhibitor is preferably 3-nitro-4-iodobenzamide; administered orally, topically, parenerally, transdermally, or rectally; anticarcinogenic and antidiabetic agents; obesity, cardiovascular disease |
| 05/01/2008 | US20080103188 Novel bicyclic compounds as modulators of androgen receptor function |
| 05/01/2008 | US20080103185 Chloroacylation of 4-[(2,4-dioxothiazolidin-5-yl)methyl]phenoxyacetic acid; amidation of tert-butyl N-(2-amino-5-methoxyphenyl)-N-methylcarbamate; cyclizing to 5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}thiazolidine-2,4-dione; reflux purification; highly stable antidiabetic agents |
| 05/01/2008 | US20080103183 New imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103179 For treating diabetes, hypertension, migraine, epilepsy, sleep apnea, depression, impulse control disorders or alcohol addiction; coadministering a sympathomimetic agent such as phentermine and an anticonvulsant sulfamate or sulfonylurea, preferably topiramate or zonisamide; side effect reduction |
| 05/01/2008 | US20080103172 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases |
| 05/01/2008 | US20080103147 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/01/2008 | US20080103146 Highly Selective Norepinephrine Reuptake Inhibitors And Methods Of Using The Same |
| 05/01/2008 | US20080103145 Administering racemic reboxetine component |
| 05/01/2008 | US20080103142 c-Jun N-terminal kinase and cyclin-dependent kinase inhibitor; (4-benzotriazol-1-yl-5-chloro-pyrimidin-2-yl)-cyclohexyl-amine; antiinflammatory and anticarcinogenic agent; autoimmune and neurodegenerative disorders; rheumatoid arthritis, asthma, type II diabetes, Alzheimer's and Parkinson's diseases |
| 05/01/2008 | US20080103141 tert-Butyl 4-[({5-[4-(hydroxymethyl)phenyl]pyrimidin-2-yl}oxy)methyl]piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy, obesity; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 05/01/2008 | US20080103138 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103123 4-phenyl-3-substituted pyridin compounds such as tert-Butyl 4-[({5-[4-(methylsulfonyl)phenyl]pyridin-2-yl}oxy)methyl]-piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 05/01/2008 | US20080103120 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/01/2008 | US20080103115 Phosphonate compounds |
| 05/01/2008 | US20080103097 Glucagon-like peptides having one lipophilic substituent which is attached to the C-terminal amino acid; treatment of non-insulin dependent diabetes mellitus |
| 05/01/2008 | US20080102081 Preparations and applications for treatment of high cholesterol levels |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102054 Aorta gonad mesoderm composition for use in treatment of nervous system, blood, inflammatory, autoimmune, skin, respiratory and liver disorders |
| 05/01/2008 | US20080102032 Methods of Treating Diabetes Using Inhibitors of ARNT2 |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1916239A1 Pyridone compound |
| 04/30/2008 | EP1916234A1 Cyclopropanecarboxylic acid compound |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1915397A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/30/2008 | EP1915391A1 Sra binding protein |
| 04/30/2008 | EP1915367A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 04/30/2008 | EP1915364A1 Pyrazole derivatives as therapeutic agents |
| 04/30/2008 | EP1915356A1 Therapeutic agents |
| 04/30/2008 | EP1915355A1 Therapeutic agents |
| 04/30/2008 | EP1915171A2 Method of preserving the function of insulin-producing cells |
| 04/30/2008 | EP1915150A1 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 04/30/2008 | EP1597259B1 Nitrogen-substituted hexahydropyrazino 1,2-a pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
| 04/30/2008 | EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 04/30/2008 | EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | CN101171231A Diacylglycerol acyltransferase inhibitors |
| 04/30/2008 | CN101171025A Novel nutraceutical compositions |
| 04/30/2008 | CN101171011A Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder |
| 04/30/2008 | CN101171002A Novel use of liver X receptor agonists |
| 04/30/2008 | CN101168060A Stable medicinal composition containing biguanide and sulfonylurea and preparation method thereof |
| 04/30/2008 | CN101168059A Stable medicinal composition containing biguanide, sulfonylurea and thiazolidinedione and preparation method thereof |
| 04/30/2008 | CN101168017A Traditional Chinese medicinal preparation for treating hyperlipomia |
| 04/30/2008 | CN101167992A Cool health-care beer capable of balanced fat-reducing, overall preventing cough and diabetes and beautifying |
| 04/30/2008 | CN101167973A Traditional Chinese medicine for treating hyperlipemia |